System pharmacology-based dissection of the potential effective material basis and mechanism of Xiaoxianxiong decoction for type 2 diabetes mellitus
Kong, Jiao, Liu, ChuanXin, Zhou, JiaLi, Li, YouZhi, Cui, XiXi, He, Tao, Ma, BaoNan, Han, Shuang, Zhang, YiNing, Huang, JianMei
Published in Traditional medicine research (2021)
Published in Traditional medicine research (2021)
Get full text
Journal Article
BBI608-224: A phase Ib/II study of cancer stemness inhibitor napabucasin (BBI-608) administered with panitumumab in KRAS wild-type patients with metastatic colorectal cancer
Larson, Tim, Ortuzar, Waldo Feliu, Bekaii-Saab, Tanios S., Becerra, Carlos, Ciombor, Kristen Keon, Hubbard, Joleen Marie, Edenfield, William Jeffery, Shao, Spencer H., Grothey, Axel, Borodyansky, Laura, Xu, Bo, Li, Wei, Li, Youzhi, Li, Chiang, Khan, Waheed
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Cancer stemness inhibition and chemosensitization: Phase 1b/II study of cancer stemness inhibitor napabucasin (BBI-608) with FOLFIRI +/- bevacizumab (Bev) administered to colorectal cancer (CRC) patients (pts)
Bendell, Johanna C., O'Neil, Bert H., Starodub, Alexander, Jonker, Derek J., Halfdanarson, Thorvardur Ragnar, Edenfield, William Jeffery, El-Rayes, Bassel F., Hubbard, Joleen Marie, Pitot, Henry C., Hobday, Timothy J., Li, Youzhi, Gao, Yuan, Grothey, Axel, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Complexity of roles and regulation of the PMK1-MAPK pathway in mycelium development, conidiation and appressorium formation in Magnaporthe oryzae
Jin, Qingchao, Li, Chanyuan, Li, Youzhi, Shang, Jinjie, Li, Debao, Chen, Baoshan, Dong, Haitao
Published in Gene Expression Patterns (01.06.2013)
Published in Gene Expression Patterns (01.06.2013)
Get full text
Journal Article
Abstract LB-47: Specific and potent silencing of K-Ras by asymmetric RNA technology reveals addiction of gastric cancer stem cells
Sun, Xiangao, Li, Youzhi, Umehara, Hiroki, Oishi, Jun, Jesuraj, Nithya, Barbulovic, Jelena, Dai, Xiaoshu, Gada, Keyur, Li, Chiang
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Abstract LB-253: Inhibition of stemness by BBI608 is sufficient to suppress cancer relapse and metastasis
Li, Youzhi, Rogoff, Harry A., Keates, Sarah, Gao, Yuan, Murikipudi, Sylaja, Mikule, Keith, Leggett, David, Li, Wei, Pardee, Arthur, Li, Chiang J.
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
A phase 1b study of the cancer stem cell inhibitor BBI608 administered with paclitaxel in patients with advanced malignancies
Hitron, Matthew, Stephenson, Joe, Chi, Kim N., Edenfield, William Jeffery, Leggett, David, Li, Youzhi, Li, Wei, Gada, Keyur, Li, Chiang
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Acclimation of Salix triandroides cuttings to incomplete submergence is reduced by low light
Ding, Xiaohui, Zou, Jianfeng, Li, Youzhi, Yao, Xin, Zou, Dongsheng, Zhang, Canming, Yang, Nan, Niu, Yandong, Bian, Hualin, Deng, Jiajun, Ge, Zixuan
Published in Aquatic ecology (01.06.2017)
Published in Aquatic ecology (01.06.2017)
Get full text
Journal Article
A phase Ib extension study of cancer stemness inhibitor BB608 (napabucasin) in combination with gemcitabine and nab-paclitaxel (nab-PTX) in patients (pts) with metastatic pancreatic cancer
El-Rayes, Bassel F., Shahda, Safi, Starodub, Alexander, O'Neil, Bert H., Hanna, Wahid Tewfik, Shaib, Walid Labib, Oh, Cindy, Li, Wei, Li, Youzhi, Borodyansky, Laura, Li, Chiang, Bekaii-Saab, Tanios S.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A phase Ib/II study of cancer stemness inhibitor napabucasin (BB608) combined with weekly paclitaxel in advanced non-small cell lung cancer
Becerra, Carlos, Spira, Alexander I., Conkling, Paul R., Richey, Stephen Lane, Hanna, Wahid Tewfik, Cote, Gregory Michael, Heist, Rebecca Suk, Langleben, Adrian, Laurie, Scott Andrew, Edenfield, William Jeffery, Kossler, Kimiko, Hume, Stephanie, Li, Youzhi, Hitron, Matthew, Li, Chiang
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase I extension clinical study of BB503, a first-in-class cancer stemness kinase inhibitor, in adult patients with advanced head and neck cancer
Cote, Gregory Michael, Chau, Nicole Grace, Spira, Alexander I., Edenfield, William Jeffery, Richards, Donald A., Richey, Stephen Lane, Laurie, Scott Andrew, Wilks, Sharon, Braiteh, Fadi S., Wang, Kemeng, Li, Youzhi, Rogoff, Harry, Hitron, Matthew, Li, Chiang
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A Phase Ib/II Study of Cancer Stemness Inhibitor Napabucasin (BB608) Combined with Weekly Paclitaxel in Advanced Triple Negative Breast Cancer
Becerra, Carlos, Braiteh, Fadi S., Spira, Alexander I., Langleben, Adrian, Panasci, Lawrence C., Vukelja, Svetislava J., Hinshaw, Ioana M., Goodwin, Rachel Anne, Panella, Timothy J., Edenfield, William Jeffery, Kossler, Kimiko, Hume, Stephanie, Li, Youzhi, Hitron, Matthew, Li, Chiang
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A phase Ib/II study of cancer stemness inhibitor napabucasin (BBI-608) in combination with gemcitabine (gem) and nab-paclitaxel (nabPTX) in metastatic pancreatic adenocarcinoma (mPDAC) patients (pts)
Bekaii-Saab, Tanios S., Starodub, Alexander, El-Rayes, Bassel F., O'Neil, Bert H., Shahda, Safi, Ciombor, Kristen Keon, Noonan, Anne M., Hanna, Wahid Tewfik, Sehdev, Amikar, Shaib, Walid Labib, Mikhail, Sameh, Neki, Anterpreet S., Oh, Cindy, Li, Youzhi, Li, Wei, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
BBI608-503-103HCC: A phase Ib/II clinical study of napabucasin (BBI608) in combination with sorafenib or amcasertib (BBI503) in combination with sorafenib (Sor) in adult patients with hepatocellular carcinoma (HCC)
El-Rayes, Bassel F., Richards, Donald A., Cohn, Allen Lee, Richey, Stephen Lane, Feinstein, Trevor, Kundranda, Madappa N., El-Khoueiry, Anthony B., Melear, Jason M., Braiteh, Fadi S., Hitron, Matthew, Ortuzar, Waldo Feliu, Khan, Waheed, Xu, Bo, Li, Wei, Li, Youzhi, Li, C J
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase 1b/II study of cancer stemness inhibitor napabucasin (BBI-608) in combination with FOLFIRI +/- bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts)
Bendell, Johanna C., Hubbard, Joleen Marie, O'Neil, Bert H., Jonker, Derek J., Starodub, Alexander, Peyton, James D., Pitot, Henry C., Halfdanarson, Thorvardur Ragnar, Nadeau, Benjamin Rolland, Zubkus, John D., Adesunloye, Bamidele, Edenfield, William Jeffery, Li, Youzhi, Li, Wei, Grothey, Axel, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase 1 dose-escalation study of BBI503, a first-in-class cancer stemness kinase inhibitor in adult patients with advanced solid tumors
Laurie, Scott Andrew, Jonker, Derek J., Edenfield, William Jeffery, Stephenson, Joe, Keller, Deborah, Hitron, Matthew, Li, Wei, Li, Youzhi, Gada, Keyur, Gao, Yuan, Li, Chiang
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A phase I extension study of BBI608, a first-in-class cancer stem cell (CSC) inhibitor, in patients with advanced solid tumors
Jonker, Derek J., Stephenson, Joe, Edenfield, William Jeffery, Supko, Jeffrey G., Li, Youzhi, Li, Wei, Hitron, Matthew, Leggett, David, Kerstein, David, Li, Chiang
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article